Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion type Assertion NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_head.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion description "[To determine the maximum tolerated dose (MTD) of the oral mTOR inhibitor everolimus in advanced HCC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_provenance.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion evidence source_evidence_literature NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_provenance.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion SIO_000772 23134470 NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_provenance.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion wasDerivedFrom befree-20140225 NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_provenance.
- NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_assertion wasGeneratedBy ECO_0000203 NP782009.RAWEr4LZVca8SkL0x0ZjDWt3VbcM85N3uApAm4uecFRCU130_provenance.